Pharmaids Pharmaceuticals Ltd (524572) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 524572 | NSE: | Pharmaceuticals & Drugs | Small Cap

Pharmaids Pharma Share Price

27.67 -2.60 -8.59%
as on 30-Mar'26 16:59

DeciZen - make an informed investing decision on Pharmaids Pharma

Based on:

M-Cap below 100cr DeciZen not available

Pharmaids Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
97.6 Cr.
52-wk low:
27.1
52-wk high:
73.5

Is Pharmaids Pharmaceuticals Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Pharmaids Pharma: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Pharmaids Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -21.2%7.6%-29.7%-3%-4.5%1%1.7%-64%-10.9%-6.9%-
Value Creation
Index
-2.5-0.5-3.1-1.2-1.3-0.9-0.9-5.6-1.8-1.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1.71.20.50.608.63.9002.38
Sales YoY Gr.--28.6%-62.5%24.4%-100%NA-53.9%-100%NA7,700%-
Adj EPS -1.2-0.8-1.1-0.200.10.1-3.5-1.4-2.1-3.5
YoY Gr.-NANANANA200%55.6%-2614.3%NANA-
BVPS (₹) 3.94.33.18.28.28.38.410.220.218.115.5
Adj Net
Profit
-0.4-0.3-0.4-0.200.10.2-7.6-5-7.3-12
Cash Flow from Ops. 00.3-0.2-0.1-0.80.4-0.3-4-3.4-7.7-
Debt/CF from Ops. 28.60000000-3.6-5.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 3.8%NA-15.9%7700%
Adj EPS NA-333%-345.1%NA
BVPS18.5%17.1%28.9%-10.2%
Share Price 17.8% 19.9% 8.3% -59.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-26.2-18.5-31.2-3.80.41.11.7-48.6-10.6-10.8-20.5
Op. Profit
Mgn %
-20.5-28.6-86-18.101.33.50-22912.2-310-195.8
Net Profit
Mgn %
-23.6-21.1-85.9-31.601.13.70-17806.3-311-151.2
Debt to
Equity
0.400000000.20.6-
Working Cap
Days
3854701,0032,9550334831071,1883,1202,145
Cash Conv.
Cycle
2092143593450312014,850655-432

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Pharmaids Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) -3.5 -3.9
TTM Sales (₹ Cr.) 8.1 25.5
BVPS (₹.) 15.5 14
Reserves (₹ Cr.) 19 14
P/BV 1.79 1.98
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 27.10 / 73.45
All Time Low / High (₹) 1.00 / 87.46
Market Cap (₹ Cr.) 97.6
Equity (₹ Cr.) 35.3
Face Value (₹) 10
Industry PE 40.8

Management X-Ray of Pharmaids Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Pharmaids Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Pharmaids Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales1.681.200.450.5608.553.9400.032.34
Operating Expenses 2.031.550.840.660.348.443.809.896.409.60
Manufacturing Costs0.110.090.0100.010000.010.08
Material Costs1.150.670.490.3608.163.570.890.021.98
Employee Cost 0.200.170.060.050.020.040.041.131.993.42
Other Costs 0.570.620.260.250.300.240.197.874.374.12
Operating Profit -0.35-0.34-0.39-0.10-0.340.110.14-9.89-6.37-7.26
Operating Profit Margin (%) -20.5%-28.6%-86.0%-18.1%-1.3%3.5%--22,912.2%-310.0%
Other Income 0.050.010.020.0100.030.0200.801.02
Interest 0.030.040000000.332.15
Depreciation 0.100.0600.050.040.040.010.020.180.20
Exceptional Items 00.5200000000
Profit Before Tax -0.430.08-0.37-0.14-0.380.090.14-9.91-6.09-8.59
Tax -0.03-0.030.020.03-0.41-0-0-2.35-1.14-1.31
Profit After Tax -0.400.11-0.39-0.180.030.090.15-7.56-4.95-7.28
PAT Margin (%) -23.6%9.1%-85.9%-31.6%-1.1%3.7%--17,805.0%-311.0%
Adjusted EPS (₹)-1.20.3-1.2-0.20.00.10.1-3.5-1.4-2.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 1.321.431.048.408.438.538.6722.0871.0663.79
Share Capital 3.363.363.3610.2710.2710.2710.2721.4435.2735.27
Reserves -2.05-1.94-2.32-1.87-1.84-1.74-1.600.6335.7928.52
Minority Interest0000000000
Debt0.48000000012.5039.40
Long Term Debt0.27000000012.5039.40
Short Term Debt0.21000000000
Trade Payables0.440.450.180.160.010.502.311.88011.38
Others Liabilities 0.060.140.070.11-0.33-0.26-0.22-2.12-2.40-1.03
Total Liabilities 2.302.021.308.678.118.7610.7621.8481.16113.54

Fixed Assets

Gross Block2.12000.460.510.510.510.1216.7524.57
Accumulated Depreciation1.68000.390.420.470.480.020.190.39
Net Fixed Assets 0.44000.080.080.040.030.1116.5524.18
CWIP 0000.450.450.450.4522.303.51
Investments 00000003.2752.6052.61
Inventories0.290.240000.370.8900.239.77
Trade Receivables1.070.790.520.8900.281.342.0500.16
Cash Equivalents 0.180.610.240.110.020.200.4112.752.460.47
Others Assets 0.320.380.547.147.567.437.641.667.0222.85
Total Assets 2.302.021.308.678.118.7610.7621.8481.16113.54

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.020.33-0.21-0.10-0.750.41-0.26-4.02-3.44-7.72
PBT -0.430.08-0.37-0.14-0.380.090.14-9.91-6.09-8.59
Adjustment 0.120.09-0.020.040.040.040.010.052.651.97
Changes in Working Capital 0.320.150.190-0.410.27-0.415.84-0-1.11
Tax Paid 00-0.020000000
Cash Flow From Investing Activity -0.080.33-0.09-00.66-0.230.47-4.94-72.51-18.90
Capex -0.080.37-0-0.02-0.04-00-1.67-16.37-9.04
Net Investments 0000000000
Others 0-0.05-0.090.010.70-0.230.47-3.27-56.14-9.87
Cash Flow From Financing Activity 0.05-0.22-0.07-0.03-00021.3165.6624.64
Net Proceeds from Shares 000000021.3153.590
Net Proceeds from Borrowing 0000000000
Interest Paid -0.02-0.0400-0000-0.27-2.10
Dividend Paid 0000000000
Others 0.07-0.18-0.07-0.03000012.3426.74
Net Cash Flow -0.010.43-0.37-0.13-0.090.180.2112.35-10.29-1.99

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-26.217.99-31.24-3.760.41.11.69-49.34-10.64-10.8
ROCE (%)-21.197.61-29.73-3.02-4.451.041.66-63.95-10.87-6.89
Asset Turnover Ratio0.70.560.270.1101.010.4000.02
PAT to CFO Conversion(x)N/A3N/AN/A-254.56-1.73N/AN/AN/A
Working Capital Days
Receivable Days237283530457012750024
Inventory Days6381000165803,011779
Payable Days13524223417601114386101,049

Pharmaids Pharmaceuticals Ltd Stock News

Pharmaids Pharmaceuticals Ltd FAQs

The current trading price of Pharmaids Pharma on 30-Mar-2026 16:59 is ₹27.67.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 29-Mar-2026 the market cap of Pharmaids Pharma stood at ₹97.59.
The latest P/E ratio of Pharmaids Pharma as of 29-Mar-2026 is 0.00.
The latest P/B ratio of Pharmaids Pharma as of 29-Mar-2026 is 1.79.
The 52-week high of Pharmaids Pharma is ₹73.45 and the 52-week low is ₹27.10.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Pharmaids Pharma is ₹8.05 ( Cr.) .

About Pharmaids Pharmaceuticals Ltd

Pharmaids Pharmaceuticals Limited Incorporated in the year 1989 at Hyderabad (Telangana, India). The company is suppliers of Quality Grade range of Specialty chemicals, Skin care, Hospital care and Generic products in the areas of Orthopedic, Neuro and Gastro etc. Its technical team uses quality proven chemical compounds and standard processing methods maintaining proper hygienic standards. Its professionals strive to offer best quality and high purity to attain maximum client's satisfaction. The company’s offered product range is highly acknowledged in the market for its precise composition long shelf life, hygienic processing techniques, premium quality and high purity.

Business area of the company

The Company is engaged in the business of Trading and Manufacturing of Generics, Bulk Drugs and Intermediaries, etc.

Products

  • Speciality Chemicals
  • Skin Care Products
  • Hospital Care Products
  • Generics
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×